Seguir
Matthew J. Ellis
Matthew J. Ellis
Physician Scientist, Oncologist
Dirección de correo verificada de bcm.edu
Título
Citado por
Citado por
Año
Comprehensive molecular portraits of human breast tumours
Cancer Genome Atlas Network
Nature 490 (7418), 61-70, 2012
10639*2012
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, J Matera, MC Miller, ...
New England Journal of Medicine 351 (8), 781-791, 2004
51272004
Supervised risk predictor of breast cancer based on intrinsic subtypes
JS Parker, M Mullins, MCU Cheang, S Leung, D Voduc, T Vickery, ...
Journal of clinical oncology 27 (8), 1160-1167, 2009
49202009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer
MCU Cheang, SK Chia, D Voduc, D Gao, S Leung, J Snider, M Watson, ...
JNCI: Journal of the National Cancer Institute 101 (10), 736-750, 2009
30332009
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National Cancer Institute 103 (22), 1656-1664, 2011
19702011
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 379 (2), 111-121, 2018
18872018
The molecular portraits of breast tumors are conserved across microarray platforms
Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ...
BMC genomics 7 (1), 1-12, 2006
18222006
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
14782016
Prospective validation of a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 373 (21), 2005-2014, 2015
14482015
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1–and/or ErbB-2–positive, estrogen receptor–positive primary breast cancer: evidence from a …
MJ Ellis, A Coop, B Singh, L Mauriac, A Llombert-Cussac, F Jänicke, ...
Journal of Clinical Oncology 19 (18), 3808-3816, 2001
14322001
Proteogenomic characterization of human colon and rectal cancer
B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ...
Nature 513 (7518), 382-387, 2014
13482014
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli, DF Hayes, GT Budd, MJ Ellis, A Stopeck, JM Reuben, ...
Journal of Clinical Oncology 23 (7), 1420-1430, 2005
13432005
Genome remodelling in a basal-like breast cancer metastasis and xenograft
LI Ding, MJ Ellis, S Li, DE Larson, K Chen, JW Wallis, CC Harris, ...
Nature 464 (7291), 999-1005, 2010
13352010
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
DF Hayes, M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, MC Miller, ...
Clinical Cancer Research 12 (14), 4218-4224, 2006
11882006
Whole-genome analysis informs breast cancer response to aromatase inhibition
MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ...
Nature 486 (7403), 353-360, 2012
11622012
CDK4/6 inhibition triggers anti-tumour immunity
S Goel, MJ DeCristo, AC Watt, H BrinJones, J Sceneay, BB Li, N Khan, ...
Nature 548 (7668), 471-475, 2017
10962017
Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer
GT Budd, M Cristofanilli, MJ Ellis, A Stopeck, E Borden, MC Miller, ...
Clinical Cancer Research 12 (21), 6403-6409, 2006
9492006
Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study
W Eiermann, S Paepke, J Appfelstaedt, A Llombart-Cussac, J Eremin, ...
Annals of Oncology 12 (11), 1527-1532, 2001
9182001
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer
TO Nielsen, JS Parker, S Leung, D Voduc, M Ebbert, T Vickery, SR Davies, ...
Clinical Cancer Research 16 (21), 5222-5232, 2010
8572010
Activating HER2 mutations in HER2 gene amplification negative breast cancer
R Bose, SM Kavuri, AC Searleman, W Shen, D Shen, DC Koboldt, ...
Cancer discovery 3 (2), 224-237, 2013
8522013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20